| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 1,652,644 | 1,611,006 | 1,488,605 | 1,573,507 | | Cost of Revenue | 1,181,618 | 1,132,494 | 1,047,595 | 1,107,198 | | | Gross Profit | 471,026 | 478,512 | 441,010 | 466,309 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 357,780 | 356,202 | 346,080 | 337,328 | | Non Recurring |
-
|
-
| 4,043 | 23,240 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 113,246 | 122,310 | 90,887 | 105,741 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,271 | 2,214 | 2,784 | 3,899 | | Earnings Before Interest And Taxes | 117,517 | 124,524 | 93,671 | 109,640 | | Interest Expense | 5,048 | 6,467 | 6,814 | 6,399 | | Income Before Tax | 112,469 | 118,057 | 86,857 | 103,241 | | Income Tax Expense | 15,639 | 38,841 | 28,922 | 33,221 | | Minority Interest | (4,324) | (11,404) |
-
| (6,258) | | | | Net Income From Continuing Ops | 109,434 | 69,024 | 59,300 | 64,779 | | | Non-recurring Events | | Discontinued Operations | 2,715 |
-
|
-
| (7,868) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 96,421 | 69,024 | 59,300 | 56,911 | | Preferred Stock And Other Adjustments |
-
| 4,449 | (4,449) |
-
| | | Net Income Applicable To Common Shares | $96,421 | $73,473 | $54,851 | $56,911 |
|
0.26% Nasdaq 
Income Statement
